Ambagon Therapeutics Appoints Gideon Bollag, Ph.D., to Scientific Advisory Board
SAN FRANCISCO, Calif., April 25, 2022 – Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered protein targets with novel molecular glues, today announced the appointment of Gideon Bollag, Ph.D., to its Scientific Advisory Board. Dr. Bollag brings extensive experience in structure-based drug discovery and the development of oncology therapeutics. “This is a perfect moment to welcome Gideon […]
Ambagon Therapeutics Appoints Gideon Bollag, Ph.D., to Scientific Advisory Board Read More »